Quantification of Alzheimer amyloid beta peptides ending at residues 40 and 42 by novel ELISA systems

The amyloid beta (Abeta) peptide is a key molecule in the pathogenesis of Alzheimer's disease. Reliable methods to detect and quantify soluble forms of this peptide in human biological fluids and in model systems, such as cell cultures and transgenic animals, are of great importance for further...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Molecular medicine (Cambridge, Mass.) Mass.), 2000-04, Vol.6 (4), p.291-302
Hauptverfasser:	Jensen, M, Hartmann, T, Engvall, B, Wang, R, Uljon, S N, Sennvik, K, Näslund, J, Muehlhauser, F, Nordstedt, C, Beyreuther, K, Lannfelt, L
Format:	Artikel
Sprache:	eng
Schlagworte:	Albumins - metabolism Alzheimer Disease - metabolism Amino Acid Sequence Amyloid beta-Peptides - analysis Amyloid beta-Peptides - chemical synthesis Amyloid beta-Peptides - chemistry Amyloid beta-Peptides - immunology Amyloid beta-Peptides - ultrastructure Antibodies, Monoclonal - immunology Antibody Specificity - immunology Cerebrospinal Fluid - chemistry Cerebrospinal Fluid - metabolism Culture Media, Conditioned - chemistry Enzyme-Linked Immunosorbent Assay - methods Epitope Mapping Humans Mass Spectrometry Microscopy, Electron Peptide Fragments - analysis Peptide Fragments - chemical synthesis Peptide Fragments - chemistry Peptide Fragments - immunology Peptide Fragments - ultrastructure Reproducibility of Results Sensitivity and Specificity Solubility Specimen Handling Temperature
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!